MedTrace Logo

Salivary LINC00657 as a Diagnostic Biomarker for Oral Squamous Cell Carcinoma

NCT05821179 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2023-04-20

No results posted yet for this study

Summary

This study was designed to verify the role of salivary LINC00657 as a diagnostic marker in oral squamous cell carcinoma (OSCC) patients as compared to oral lichen planus (OLP) (as an example of oral potentially malignant lesions) and normal individuals, and to show its relation to miR-106a. A total of 36 participants were included.

Conditions

  • Oral Squamous Cell Carcinoma

Sponsors & Collaborators

  • Fayoum University

    lead OTHER

Principal Investigators

  • Nayroz Tarrad, as. professor · faculty of dentistry, Fayoum university

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-01-01
Completion
2023-02-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05821179 on ClinicalTrials.gov